Abstract
Abstract
Purpose of Review
People with fatal neuromuscular diseases such as ALS want to access investigational products. Trials are our preferred pathway for this, but most people with these diseases will not be able to participate due to restrictive inclusion criteria, travel burdens, or design features they will not accept. This leaves FDA Expanded Access Programs (EAPs), the Right To Try (RTT) pathway, and self-purchase of alternative and off-label treatments (AOTs).
Recent Findings
A recent survey highlighted physician barriers to the above pathways, including lack of knowledge and concerns about time burdens and risks. Emerging resources are highlighted that can mitigate some of these concerns.
Summary
With the information in this chapter, we hope that neuromuscular clinicians will feel more knowledgeable and confident in supporting patient request for investigational products.
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. • Bedlack RS, Pastula DM, Welsh E, Pulley D, Cudkowicz M. Scrutinizing enrollment in ALS clinical trials: room for improvement? Amyotrophic Lateral Sclerosis 2008;9:257–265. Highlights the low enrollment in ALS trials.
2. • Bedlack RS, Wicks Paul, Heywood J, Kasarskis E. Modifiable barriers to enrollment in American ALS research studies. Amyotrophic Lateral Sclerosis 2010;11:502–507. Explains some of the barriers to enrollment in ALS trials, only some of which are easily modifiable.
3. Nichols E; Institute of Medicine (US) Roundtable for the Development of Drugs and Vaccines Against AIDS. Expanding access to investigational therapies for HIV infection and AIDS: March 12–13, 1990 Conference Summary. Washington (DC): National Academies Press (US). 1991;1. Historical Perspective. Available from: https://www.ncbi.nlm.nih.gov/books/NBK234129/
4. US Food and Drug Administration webpage on Expanded Access. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=312&showFR=1&subpartNode=21:5.0.1.1.3.9 (2020). Accessed 5-May-2021.
5. National Institute of Health Center for Leading Innovation & Collaboration. https://clic-ctsa.org/groups/teamss/navigating-expanded-access#section1 (2020). Accessed 6-May-2021.